Bone Marrow TransplantationBone NeoplasmsBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningTissue DonorsGraft SurvivalTransplantation ChimeraHematopoietic Stem CellsHistocompatibility TestingBone Marrow PurgingHistocompatibilityBone Marrow DiseasesBusulfanBone Marrow ExaminationImmunosuppressive AgentsBone RemodelingMice, Inbred C57BLHematopoiesisTransplantation, IsogeneicKidney TransplantationHematologic NeoplasmsCyclophosphamideLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceBone Marrow NeoplasmsCytomegalovirus InfectionsRadiation ChimeraTime FactorsGraft RejectionLiver TransplantationImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaTreatment OutcomeCombined Modality TherapyAcute DiseaseCyclosporineHepatic Veno-Occlusive DiseaseLymphocyte DepletionGraft vs Host ReactionBone DensityT-LymphocytesLeukemia, MyeloidRemission InductionRetrospective StudiesColony-Forming Units AssayHLA AntigensSurvival AnalysisLymphoma, Non-HodgkinHematologic DiseasesOpportunistic InfectionsMyelodysplastic SyndromesImmunocompromised HostNuclear FamilyLeukocyte TransfusionBone ResorptionChimeraTransplantation ImmunologySevere Combined ImmunodeficiencyCell DifferentiationHeart TransplantationStem Cell TransplantationLymphocyte TransfusionFatal OutcomeSpleenMice, Inbred BALB CLeukocyte CountFlow CytometryActuarial AnalysisCells, CulturedFollow-Up StudiesSurvival RateLung TransplantationAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalMultiple MyelomaPancytopeniaCytomegalovirusAntilymphocyte SerumAntigens, CD34Mice, KnockoutInfectionGranulocyte Colony-Stimulating FactorPneumonia, ViralBlood Group IncompatibilityMycosesGranulocytesGraft vs Tumor EffectPolymerase Chain ReactionHodgkin DiseaseLymphoma